Company Overview
- Website
- avax-tech.com
- Phone
- (215) 241-9760
- Employees
- 6
- Founded in
- 1998
- Industry
- BioTech/Drugs
- NAICS Codes
-
32 - Manufacturing325 - Chemical Manufacturing3254 - Pharmaceutical and Medicine Manufacturing32541 - Pharmaceutical and Medicine Manufacturing54 - Professional, Scientific, and Technical Services541 - Professional, Scientific, and Technical Services5417 - Scientific Research and Development Services
- SIC Codes
-
28 - Chemicals and Allied Products283 - Drugs
Financials & Stats
Revenue
$1B
Recent News & Media
Clinical evaluation of therapeutic cancer vaccines
- Nov 4, 2024
- pmc.ncbi.nlm.nih.gov
Autologous, hapten-modified vaccine as a treatment for human cancers
- Jun 17, 2023
- sciencedirect.com
BioVaxys Co-Founder, President and Chief Operating Officer Kenne
- Dec 5, 2022
- gurufocus.com
TRYP THERAPEUTICS INC. ANNOUNCES BOARD CHANGES AND CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT
- Jun 29, 2022
- psychedelicalpha.com
Terrorists could make a 'dirty bomb' from this common medical device; why regulators won't act
- Dec 27, 2019
- latimes.com
Long lasting p53‐specific T cell memory responses in the absence of anti‐p53 antibodies in patients with resected primary colorectal cancer - van der Burg - 2001 - European Journal of Immunology
- Sep 2, 2018
- onlinelibrary.wiley.com
Who is AVAX Technologies Inc
AVAX Technologies, Inc. is a biotechnology company based in Philadelphia, Pennsylvania. The company employs six people and generates annual revenue of $0.75 million. AVAX Technologies specializes in developing and commercializing its AC Vaccine® technology, a platform designed for the treatment of cancer. This technology focuses on creating personalized cancer vaccines, a complex and unique approach in the field of immuno-oncology. AVAX Technologies distinguishes itself through its advanced stage of development and commercial readiness within the immuno-oncology sector. The company operates a GMP approved facility, one of the few globally capable of producing autologous vaccine products. For more information about AVAX Technologies and its innovative cancer vaccine technology, please visit www.avax-tech.com.